1. Home
  2. AWF vs AMPH Comparison

AWF vs AMPH Comparison

Compare AWF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliancebernstein Global High Income Fund

AWF

Alliancebernstein Global High Income Fund

HOLD

Current Price

$10.09

Market Cap

864.9M

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$16.84

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWF
AMPH
Founded
1993
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
864.9M
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
AWF
AMPH
Price
$10.09
$16.84
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$28.38
AVG Volume (30 Days)
513.4K
544.9K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
7.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
N/A
$4.64
P/E Ratio
N/A
$124.00
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$17.03
52 Week High
$11.43
$31.26

Technical Indicators

Market Signals
Indicator
AWF
AMPH
Relative Strength Index (RSI) 39.76 31.72
Support Level $9.99 N/A
Resistance Level $10.24 $24.16
Average True Range (ATR) 0.11 0.86
MACD -0.03 -0.62
Stochastic Oscillator 8.51 2.44

Price Performance

Historical Comparison
AWF
AMPH

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: